Home Jazz Jazz Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 9, 2021 | New

Jazz Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 9, 2021 | New

0


DUBLIN, October 26, 2021 / PRNewswire / – Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will release its third quarter 2021 financial results on Tuesday, November 9, 2021 after the close of US financial markets. Company management will host a live audio webcast at 4:30 p.m. ET/9:30 p.m. IST to discuss the financial results for the third quarter of 2021 and provide a business and financial update.

Audio webcast / conference call:

US phone number: +1 855 353 7924

International phone number: +1 503 343 6056

Access code: 5888822

A replay of the conference call will be available via November 16, 2021.

Replay US call number: +1 855 859 2056

Replay International phone number: +1 404 537 3406

Access code: 5888822

Interested parties can access the live audio webcast through the Investors section of the Jazz Pharmaceuticals website at www.jazzpharma.com.

About Jazz Pharmaceuticals

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company dedicated to innovating to transform the lives of patients and their families. We are committed to developing drugs that change the lives of people with serious illnesses – often with limited or no treatment options. We have a diverse portfolio of commercialized drugs and new product candidates, from early to late stage development, in neuroscience and oncology. We are actively exploring new options for patients, including new compounds, small molecules and biologics, as well as through cannabinoid science and innovative delivery technologies. Jazz is headquartered at Dublin, Ireland and has employees around the world, serving patients in nearly 75 countries. For more information, please visit www.jazzpharma.com and follow @JazzPharma on Twitter.

Jazz Pharmaceuticals contact details:

Investors:

Andrea N. Flynn, Ph.D.

Vice-President, Head, Investor Relations

Jazz Pharmaceuticals plc

[email protected]

Ireland, +353 1 634 3211

United States, +1 650 496 2717

Media:

Kristin bhavnani

Head of Global Corporate Communication

Jazz Pharmaceuticals plc

[email protected]

Ireland, +353 1 697 2141

United States, +1 215 867 4948

View original content to download multimedia: https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-report-2021-three-quarter-financial-results-on-november-9-2021-301408999 .html

SOURCE Jazz Pharmaceuticals plc